Why are you guys even discussing whether ARIA has "earnings"???
The company has no sales, no revenues, no approved product to sell.
There are NO "earnings"....
This company isn't an "earnings" story for YEARS.
The only thing that you should be worried about is Ridaforolimus in the SUCCEED trial (and to a large extent, the endometrial trials coming out soon), and what they plan on doing for '534. Earnings are entirely irrelevant and the "Street" isn't even remotely concerned about "earnings" because there are none, and won't be, for years.
Ariad, for accounting purposes, may use the Merck money to account for "earnings" but, only someone who is completely unfamiliar with biotech or this company could only confuse those numbers with real "earnings"